Literature DB >> 3653359

Viridans streptococci septicemia in cancer patients: a clinical study.

F Menichetti1, A Del Favero, R Guerciolini, M Tonato, R F Frongillo, F Roila, S Pauluzzi.   

Abstract

Viridans streptococci septicemia was documented in ten cancer patients, 7 of whom were neutropenic (less than 1000/mmc). Pneumonia was presumed to be the source of bacteremia in six patients. Viridans streptococci isolated from sputum culture in an immunocompromised host must be regarded as the potential etiological agent, then further characterized and checked for antibiotic sensitivity.

Entities:  

Mesh：

Year:  1987        PMID： 3653359     DOI： 10.1007/BF00149743

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  5 in total

1.  Serious infections caused by Streptococcus milleri.

Authors:  H W Murray; K C Gross; H Masur; R B Roberts
Journal:  Am J Med       Date:  1978-05       Impact factor: 4.965

2.  Viridans streptococcal pulmonary parenchymal infections.

Authors:  M R Pratter; R S Irwin
Journal:  JAMA       Date:  1980-06-27       Impact factor: 56.272

3.  Neutropenia, fever, and infection.

Authors:  A E Brown
Journal:  Am J Med       Date:  1984-03       Impact factor: 4.965

4.  Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia.

Authors:  J Cohen; J P Donnelly; A M Worsley; D Catovsky; J M Goldman; D A Galton
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

5.  Physiological differentiation of viridans streptococci.

Authors:  R R Facklam
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948
  5 in total
  8 in total

1.  Antimicrobial susceptibility of viridans group streptococci isolated from patients with acute leukemia receiving ofloxacin for antibacterial prophylaxis.

Authors:  W Kern; K Linzmeier; E Kurrle
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

2.  Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients.

Authors:  M Venditti; P Baiocchi; C Santini; C Brandimarte; P Serra; G Gentile; C Girmenia; P Martino
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

3.  Emergence of penicillin-resistant viridans streptococci causing septicemia in granulocytopenic patients.

Authors:  C Santini; M Venditti; P Baiocchi; C Brandimarte; P Serra; F Mandelli; C Girmenia; A Micozzi; P Martino
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

4.  Evaluation of penicillin G in the prevention of streptococcal septicaemia in patients with acute myeloid leukaemia undergoing cytotoxic chemotherapy.

Authors:  P de Jong; M de Jong; E Kuijper; J van der Lelie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

5.  A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.

Authors:  W V Kern; B Hay; P Kern; R Marre; R Arnold
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

6.  Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases.

Authors:  W Kern; E Kurrle; T Schmeiser
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

Review 7.  Clinical implications of positive blood cultures.

Authors:  C S Bryan
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

8.  Defining antibody targets in Streptococcus oralis infection.

Authors:  J P Burnie; W Brooks; M Donohoe; S Hodgetts; A al-Ghamdi; R C Matthews
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.